Clin2
NCT06007534Possibly a fitRecruiting

Doxycycline for STI Prevention After Sex

Post-exposure ProphylaxisSexually Transmitted DiseasesDoxycycline

Part of Infections clinical trials.

This study looks at how a single 200 mg dose of doxycycline works in the body to prevent bacterial sexually transmitted infections (like chlamydia, gonorrhea, and syphilis) after a risky sexual encounter. It is for men who have sex with men and are already on PrEP or living with HIV.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
25 people
Ages
18 years to 100 years
Study type
Interventional

Who can take part

  • You are an adult male
  • You are a man who has sex with men and are on PrEP or living with HIV
  • You have not taken doxycycline in the last 3 months
  • You have had a bacterial STI in the past 12 months
  • You had a risky sexual encounter within the last 24 to 72 hours

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07500415Recruiting
Doxycycline to prevent STIs in Rio de Janeiro

This trial tests whether taking the antibiotic doxycycline can prevent sexually transmitted infections (STIs) like chlamydia, gonorrhea, and syphilis in people at higher risk. If you are a man or transgender woman who has sex with men, are living with HIV or on PrEP, and have had an STI in the past year, you may be able to join.

Rio de Janeiro, Rio de Janeiro
NCT06778083Recruiting
Antibiotic to prevent STIs and its effect on resistance

This study looks at taking doxycycline to prevent sexually transmitted infections (STIs) in men who have sex with men. It focuses on how this approach might affect the body's resistance to antibiotics.

London
NCT07767422Not yet recruiting· Phase 2
Short doxycycline course for anal chlamydia infection

This trial tests whether a 7-day course of doxycycline is effective for treating an anal chlamydia infection (lymphogranuloma venereum) in people who do not have symptoms. Participants will take the antibiotic for a week and be followed for four weeks.

Bordeaux
NCT05897034Not yet recruiting· Phase 2/Phase 3
Study antibiotics for untreated gonorrhea and chlamydia

This trial tests a combination of medications (doxycycline, pentoxifylline, and nitazoxanide) in men with untreated gonorrhea and chlamydia. It may help clear the infection more effectively, but you must meet specific safety and health criteria.

NCT04762134Recruiting
Doxycycline to prevent future bacterial STIs in high-risk men

This trial tests whether taking doxycycline can lower the chance of getting bacterial sexually transmitted infections like syphilis, gonorrhea, and chlamydia. It is aimed at men who have had these infections recently and expect to keep having multiple male partners.

Calgary, Alberta
NCT06738407Recruiting· Phase 4
Doxycycline to prevent STIs in high-risk people

This study tests whether taking a daily antibiotic (doxycycline) can prevent sexually transmitted infections in people at high risk. If you've had an STI recently and sometimes have sex without condoms, you might be able to join.

Los Angeles, California

Hear when a new Sexually Transmitted Diseases trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.